Boston Partners Reduces Stake in Molina Healthcare, Inc (NYSE:MOH)

Key Points

• Boston Partners has reduced its stake in Molina Healthcare, Inc. by 40%, now owning approximately 573,223 shares, valued at $188.8 million.
• Several institutional investors have made significant changes to their holdings in Molina Healthcare, including Bessemer Group Inc. and Bridgewater Associates LP, which increased their stakes by over 100% in recent quarters.
• Analysts have recently lowered their price targets for Molina Healthcare, with consensus ratings reflecting a shift towards a "Hold" stance, despite a strong revenue increase reported last quarter.

Boston Partners lessened its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 40.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 573,223 shares of the company's stock after selling 381,947 shares during the quarter. Boston Partners owned about 1.06% of Molina Healthcare worth $188,801,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. GAMMA Investing LLC boosted its position in Molina Healthcare by 74,593.7% during the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after buying an additional 666,122 shares during the period. Voloridge Investment Management LLC raised its stake in shares of Molina Healthcare by 1,641.3% in the fourth quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock worth $119,274,000 after purchasing an additional 386,273 shares during the last quarter. Two Sigma Investments LP bought a new position in Molina Healthcare during the 4th quarter valued at $44,099,000. Nuveen LLC bought a new position in shares of Molina Healthcare during the first quarter valued at about $46,441,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Molina Healthcare by 138.4% during the 4th quarter. BNP Paribas Financial Markets now owns 177,150 shares of the company's stock worth $51,560,000 after buying an additional 102,840 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Trading Up 4.9%

Molina Healthcare stock traded up $7.77 during mid-day trading on Friday, reaching $167.40. 1,711,113 shares of the company traded hands, compared to its average volume of 2,291,864. The firm's 50 day moving average price is $223.29 and its 200 day moving average price is $281.79. The firm has a market capitalization of $9.07 billion, a price-to-earnings ratio of 8.25 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business's revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.86 earnings per share. On average, analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, COO James Woys bought 10,000 shares of the firm's stock in a transaction on Monday, August 4th. The stock was acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the purchase, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on MOH. UBS Group cut their price target on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Mizuho lowered their price target on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a research report on Friday, July 11th. Wells Fargo & Company cut their price objective on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a research report on Friday. Morgan Stanley cut shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $364.00 to $266.00 in a research report on Thursday, July 10th. Finally, Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and a consensus price target of $242.91.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.